David S. Goldfarb

Challenging patient phenotypes in the management of anaemia of chronic kidney disease

D. Goldfarb, Sheena Pramod, David S. Goldfarb, 2021, International journal of clinical practice.

Radioisotope blood volume measurement in hemodialysis patients

Sonika PURI, Jun-Ki PARK, Frank MODERSITZKI, 2014, Hemodialysis international. International Symposium on Home Hemodialysis.

A Summary of Current Guidelines and Future Directions for Medical Management and Monitoring of Patients with Cystinuria

David S. Goldfarb, Sarah M. Azer, D. Goldfarb, 2023, Healthcare.

Potassium citrate decreases urine calcium excretion in patients with hypocitraturic calcium oxalate nephrolithiasis

B. Eisner, D. Goldfarb, Yan Song, 2016, Urolithiasis.

Pilot study of probiotic dietary supplementation for promoting healthy kidney function in patients with chronic kidney disease

E. Friedman, D. Goldfarb, P. Tam, 2010, Advances in therapy.

Nedosiran in primary hyperoxaluria subtype 3: results from a phase I, single-dose study (PHYOX4)

J. Lieske, J. Groothoff, G. Schalk, 2023, Urolithiasis.

Healthcare utilization, quality of life, and work productivity associated with primary hyperoxaluria: a cross-sectional web-based US survey

F. Modersitzki, J. Li-McLeod, J. Karafilidis, 2023, Urolithiasis.

Immune complex glomerulonephritis in patients coinfected with human immunodeficiency virus and hepatitis C virus.

D. Goldfarb, R. Brody, M. Stokes, 1997, American journal of kidney diseases : the official journal of the National Kidney Foundation.

SUBCUTANEOUS COMPARED WITH INTRAVENOUS EPOETIN IN PATIENTS RECEIVING HEMODIALYSIS

D. Reda, D. Goldfarb, W. Henderson, 1998 .

Clinical use of cystine supersaturation measurements.

D. Goldfarb, F. Coe, J. Parks, 2000, Journal of Urology.

Urinary cystine excretion and capacity in patients with cystinuria.

D. Goldfarb, F. Coe, J. Asplin, 2006, Kidney international.